City of Hope, a NCI-designated Comprehensive Cancer Center
Skip Navigation
Michael A. Friedman, M.D.Director626-256-4673, ext. 68460mfriedman@coh.org
Theodore G. Krontiris, M.D., Ph.D.Director Emeritus626-256-4673, ext. 65085tkrontiris@coh.org
Richard Jove, Ph.D.Deputy Director for Basic Research626-256-4673, ext. 62357rjove@coh.org
Alexandra Levine, M.D., M.A.C.P.Medical Director626-256-4673, ext. 60213alevine@coh.org
John A. Zaia, M.D.Deputy Director for Clinical Research626-256-4673, ext. 67149jzaia@coh.org
Amy BarachAssociate Director for Administration626-256-4673, ext. 32630abarach@coh.org
Smita Bhatia, M.D., M.P.H.Associate Director for Population Research626-256-4673, ext. 67321sbhatia@coh.org
Linda H. Malkas, Ph.D.Associate Director for Basic Science626-256-4673, ext. 68423lmalkas@coh.org
Joyce C. Niland, Ph.D.Associate Director for Information Sciences626-256-4673, ext. 63032jniland@coh.org
Douglas Stahl, Ph.D., M.B.A.Vice President - Clinical Research Operations626-256-4673, ext. 64289dstahl@coh.org
Yun Yen, M.D., Ph.D.Associate Director for Translational Research626-256-4673, ext. 65707yyen@coh.org
Ravi Bhatia, M.D.Co-leader, Hematologic Malignancies626-256-4673, ext. 62705rbhatia@coh.org
Smita Bhatia, M.D., M.P.H.Co-leader, Cancer Control and Population Sciences626-256-4673, ext. 67321sbhatia@coh.org
Stephen J. Forman, M.D., F.A.C.P.Co-leader, Hematologic Malignancies626-256-4673, ext. 62403sforman@coh.org
David Horne, Ph.D.Co-leader, Developmental Cancer Therapeutics626-256-4673, ext. 67310dhorne@coh.org
Linda H. Malkas, Ph.D.Co-leader, Molecular Oncology626-256-4673, ext. 68423lmalkas@coh.org
Susan L. Neuhausen, Ph.D.Co-leader, Cancer Control and Population Sciences 626-256-4673, ext. 69261sneuhausen@coh.org
Andrew Raubitschek, M.D.Co-leader, Cancer Immunotherapeutics626-256-4673, ext. 62451araubitschek@coh.org
Binghui Shen, Ph.D.Co-leader, Molecular Oncology626-256-4673, ext. 64150bshen@coh.org
Yun Yen, M.D., Ph.D.Co-leader, Developmental Cancer Therapeutics626-256-4673, ext. 65707yyen@coh.org
Hua Yu, Ph.D.Co-leader, Cancer Immunotherapeutics626-256-4673, ext. 63365hyu@coh.org